Candover loses another investment, delays fund decision

As stakeholders discuss what to do with the firm’s suspended €3bn 2008 fund, Candover has lost control of laboratory business ALcontrol to GSO Capital.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this